Cargando…

Impact of Impella RP Versus Vasoactive Treatment on Right and Left Ventricular Strain in a Porcine Model of Acute Cardiogenic Shock Induced by Right Coronary Artery Embolization

BACKGROUND: The response of the left ventricle to cardiogenic shock (CS) caused by right ventricular (RV) infarction and the effect of treatment with either vasoactive treatment or Impella RP are not well described. We sought to determine RV and left ventricular longitudinal strain (LS) by echocardi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Frederiksen, Peter H., Josiassen, Jakob, Udesen, Nanna L. J., Linde, Louise, Helgestad, Ole K., Banke, Ann, Jensen, Lisette O., Schmidt, Henrik, Hassager, Christian, Ravn, Hanne B., Møller, Jacob E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9973621/ https://www.ncbi.nlm.nih.gov/pubmed/36734350 http://dx.doi.org/10.1161/JAHA.122.027831

Ejemplares similares

Unloading using Impella CP during profound cardiogenic shock caused by left ventricular failure in a large animal model: impact on the right ventricle
por: Josiassen, Jakob, et al.
Publicado: (2020)

Impact of concomitant vasoactive treatment and mechanical left ventricular unloading in a porcine model of profound cardiogenic shock
por: Udesen, Nanna L. J., et al.
Publicado: (2020)

Vasoactive pharmacological management according to SCAI class in patients with acute myocardial infarction and cardiogenic shock
por: Udesen, Nanna Louise Junker, et al.
Publicado: (2022)

Contemporary trends in use of mechanical circulatory support in patients with acute MI and cardiogenic shock
por: Helgestad, Ole Kristian Lerche, et al.
Publicado: (2020)

Hemodynamic and metabolic recovery in acute myocardial infarction-related cardiogenic shock is more rapid among patients presenting with out-of-hospital cardiac arrest
por: Josiassen, Jakob, et al.
Publicado: (2020)

Impella RP for Patients with Acute Right Ventricular Failure and Cardiogenic Shock: A Subanalysis from the IMP-IT Registry
por: Botti, Giulia, et al.
Publicado: (2022)

miRNA-200b—A Potential Biomarker Identified in a Porcine Model of Cardiogenic Shock and Mechanical Unloading
por: Riehle, Christian, et al.
Publicado: (2022)

Impella to Treat Acute Myocardial Infarct-Related Cardiogenic Shock
por: Møller, Jacob Eifer, et al.
Publicado: (2022)

Influence of Timing and Predicted Risk on Mortality in Impella-Treated Infarct-Related Cardiogenic Shock Patients
por: Schäfer, Andreas, et al.
Publicado: (2020)

Hemodynamic Support Using Percutaneous Transfemoral Impella 5.0 and Impella RP for Refractory Cardiogenic Shock
por: Dalal, Pratik K., et al.
Publicado: (2019)

Phenotyping Cardiogenic Shock
por: Zweck, Elric, et al.
Publicado: (2021)

Impella RP Use in Refractory Cardiogenic Shock in a Patient Presenting With Acute Right Coronary Artery Occlusion: A Case Report
por: Abdel Jawad, Mohammad, et al.
Publicado: (2023)

Two cases of successful treatment of acute right heart failure with Impella RP®
por: Santer, David, et al.
Publicado: (2020)

Impella RP: A Promising Intervention in Acute Right Ventricular Failure Caused by Massive Pulmonary Embolism
por: Taha, Ahmed, et al.
Publicado: (2019)

Data on association between QRS duration on prehospital ECG and mortality in patients with confirmed STEMI
por: Hansen, Rikke, et al.
Publicado: (2017)

Impella RP as a bridge to cardiac transplant for refractory late right ventricular failure in setting of left ventricular assist device
por: Randhawa, Varinder Kaur, et al.
Publicado: (2020)

The “Right” Side of Cardiogenic Shock
por: Brailovsky, Yevgeniy, et al.
Publicado: (2020)

Impella RP as Rescue Measure for Pulmonary Embolism With Hemodynamic Compromise
por: Lashin, Hazem, et al.
Publicado: (2019)

Impella CP use in patients with non‐ischaemic cardiogenic shock
por: Maniuc, Octavian, et al.
Publicado: (2019)

Ventricular Unloading Using the Impella(TM) Device in Cardiogenic Shock
por: Attinger-Toller, Adrian, et al.
Publicado: (2022)

Usefulness of Impella support in different clinical settings in cardiogenic shock
por: Barrionuevo-Sánchez, María Isabel, et al.
Publicado: (2022)

IABP versus Impella Support in Cardiogenic Shock: “In Silico” Study
por: De Lazzari, Beatrice, et al.
Publicado: (2023)

Concomitant Use of VA-ECMO and Impella Support for Cardiogenic Shock
por: Modi, Shan P., et al.
Publicado: (2023)

Impella versus IABP in acute myocardial infarction complicated by cardiogenic shock
por: Alushi, Brunilda, et al.
Publicado: (2019)

Use of Impella heart pump for management of women with peripartum cardiogenic shock
por: Elkayam, Uri, et al.
Publicado: (2019)

Impella use in real-world cardiogenic shock patients: Sobering outcomes
por: Abdullah, Khaled Q. A., et al.
Publicado: (2021)

Impella support as a bridge to heart surgery in patients with cardiogenic shock
por: Saito, Shunsuke, et al.
Publicado: (2022)

The Therapeutic Use of Impella Device in Cardiogenic Shock: A Systematic Review
por: Munoz Tello, Carlos, et al.
Publicado: (2022)

A Clinical Update on Vasoactive Medication in the Management of Cardiogenic Shock
por: Shankar, Aditi, et al.
Publicado: (2022)

Vasoactive pharmacologic therapy in cardiogenic shock: a critical review
por: Kaddoura, Rasha, et al.
Publicado: (2021)

Right ventricular function and vasoactive peptides for early prediction of bronchopulmonary dysplasia
por: Neumann, Roland P., et al.
Publicado: (2021)

Management and outcome of patients supported with Impella 5.0 for refractory cardiogenic shock
por: Gaudard, Philippe, et al.
Publicado: (2015)

Correction: Impella versus IABP in acute myocardial infarction complicated by cardiogenic shock
Publicado: (2019)

The role of the axillary Impella 5.0 device on patients with acute cardiogenic shock
por: Tarabichi, Saeed, et al.
Publicado: (2020)

Cardiogenic shock in thyroid storm: A biventricular impella (Bi‐Pella) approach
por: Caruso, Evan, et al.
Publicado: (2021)

Impella Support as a Bridge to Surgery for Severe Mitral Regurgitation With Cardiogenic Shock
por: Imaoka, Shusuke, et al.
Publicado: (2021)

IMPELLA(®) or Extracorporeal Membrane Oxygenation for Left Ventricular Dominant Refractory Cardiogenic Shock
por: Schurtz, Guillaume, et al.
Publicado: (2021)

Hemostasis Matters in a Patient With an Impella 5.0 for Refractory Cardiogenic Shock
por: Nishimoto, Yuji, et al.
Publicado: (2021)

Renal Protection and Hemodynamic Improvement by Impella(®) Microaxial Pump in Patients with Cardiogenic Shock
por: Patsalis, Nikolaos, et al.
Publicado: (2022)

Subclinical Aortic Insufficiency Causing Cardiogenic Shock Years After Impella Placement
por: Syed, Ali, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_027tt2dg308gp3c11ahofe58ne